Actelion Ltd. | Mutual Funds
Mutual Funds that own Actelion Ltd.
Government Pension Fund - Global (The)
1,882,762
1.75%
1,882,762
0.05%
12/31/2016
Stichting Pensioenfonds ABP (Global Equity Portfolio)
345,178
0.32%
345,178
0.02%
12/31/2016
Canada Pension Plan
264,000
0.25%
26,000
0.03%
03/31/2017
UBS (Lux) Equity SICAV - European Opportunity Unconstrained
201,772
0.19%
201,772
1.47%
11/30/2016
Vanguard Total International Stock Index Fund
188,110
0.18%
0
0.02%
10/31/2017
UBAM - Swiss Equity
182,132
0.17%
182,132
3.09%
12/31/2016
British Columbia Inv Management Corp.
179,585
0.17%
-3,764
0.05%
03/31/2016
FundLogic Alt. Plc - MS PSAM Global Event UCITS Fund
142,174
0.13%
142,174
6.09%
01/31/2017
State of Wisconsin Invt. Board-Core Retirement Invt. Trust Fd.
126,476
0.12%
43,294
0.04%
12/31/2016
CPR Silver Age
118,021
0.11%
-14,105
2.17%
12/30/2016
| Address |
Gewerbestrasse 16
Allschwil Basel-Landschaft (Basle Country) 4123
Switzerland
|
|
Employees
|
- |
| Website |
http://www.actelion.com |
| Updated |
07/08/2019 |
| Actelion Ltd. operates as a holding company with interests in developing, producing and marketing pharmaceutical drugs. It is a biopharmaceutical company, which focuses on the drug discovery, development, registration, production and commercialization of innovative drugs for diseases with significant unmet medical needs. Its portfolio of PAH treatments covers the spectrum of disease, from WHO Functional Class (FC) II through to FC IV, with oral, inhaled and intravenous medications. |
